 Preliminary Results for the Year Ended 31 December 2020 ABINGDON, OXFORDSHIRE ACCESSWIRE April 30, 2021 Midatech Pharma PLC AIM:MTPH.L; NASDAQ:MTP, a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicines, announces its audited preliminary results for the year ended 31 December 2020. Following the announcement of a Strategic Review in March 2020 and the termination of further in-house development of MTD201, the Company has broadened its RD pipeline through technology collaborations with third party pharmaceutical companies, the initiation of new internal programmes and adding new indications to MTX110. 